Charles River Laboratories CRL Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's increase (decrease) in accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's increase (decrease) in accounts receivable?
- Charles River Laboratories (CRL) reported increase (decrease) in accounts receivable of $65.32M in Q1 2026.
- How has Charles River Laboratories's increase (decrease) in accounts receivable changed year-over-year?
- Charles River Laboratories's increase (decrease) in accounts receivable increased by 122.5% year-over-year, from $29.35M to $65.32M.
- What does increase (decrease) in accounts receivable mean?
- The net change in money owed to the company by its customers during the period.
- How do you interpret increase (decrease) in accounts receivable?
- A decrease is generally positive as it indicates efficient cash collection, while a sustained increase may signal liquidity pressure or credit issues.
- How does increase (decrease) in accounts receivable compare across companies?
- Standard working capital metric; peers with similar business models should show consistent trends relative to revenue growth.